AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.040
-0.020 (-1.89%)
Jun 2, 2025, 10:26 AM - Market open
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $31.38 million as of June 2, 2025. Its market cap has decreased by -54.46% in one year.
Market Cap
31.38M
Enterprise Value
-34.47M
1-Year Change
-54.46%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $31.38M, a decrease of -88.84%. That is a compound annual growth rate of -49.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 31.99M | -22.43% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |